Tiger-X — Class I drug recall D-0101-2017
Terminated recall by SOS Telecom Inc., reported 2016-10-26, distributed in NY. Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/
| Recall number | D-0101-2017 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SOS Telecom Inc., Bayside, NY, United States |
| Recall initiated | 2016-05-12 |
| Classified | 2016-10-14 |
| Reported by FDA | 2016-10-26 |
| Terminated | 2018-07-06 |
| Distributed | NY |
| Reason classes | undeclared allergen, unapproved product |
| Lot numbers | 9236999 |
| Expiration dates | 2016-12-16 |
Product
Tiger-X, 1200 mg, 1 capsule per pack , 24 single packs per box
Reason for recall
Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0101-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.